Investments†—101.6%
|
Investment
Type
|
|
|
Acquisition
Date
|
Cost
|
Fair
Value
|
Direct Investments—82.7%
|
||||||
Direct Equity—47.7%
|
||||||
Information Technology—3.6%
|
||||||
Fremman 1 MM Co-investment 7 Rocket SCSp*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
02/13/2024
|
$1,076,110
|
$1,032,727
|
||
Consumer Discretionary—3.7%
|
||||||
Huracan68 S.p.A (Class B Shares)*(1)(2)(4)(5)
(33,550 shares)
|
Common Stock
|
10/01/2024
|
885,360
|
828,680
|
||
Huracan68 S.p.A (Shareholder loan), 04/03/2032*(1)(2)(4)(5)(6)
|
Loan Notes
|
10/01/2024
|
221,340
|
207,170
|
||
Information Technology—4.6%
|
||||||
Stirling Square Capital Partners Eagle Co-Investment SCSp*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
11/13/2023
|
1,012,231
|
1,293,188
|
||
Consumer Discretionary—4.1%
|
||||||
BPCP NSA Holdings, Inc. (Class A Preferred Stock, 8.00%)*(1)(2)(4)(5)(7)
(572 shares)
|
Preferred Stock
|
05/15/2024
|
858,275
|
902,196
|
||
BPCP NSA Holdings, Inc. (Common Stock)*(1)(2)(4)(5)
(286 shares)
|
Common Stock
|
05/15/2024
|
286,092
|
242,164
|
||
Health Care—6.9%
|
||||||
NanoVista*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
04/23/2024
|
1,145,300
|
1,144,963
|
||
Resurgens II Co-Invest C, L.P.*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
11/15/2023
|
656,895
|
790,029
|
||
Industrials—4.5%
|
||||||
ATEX Blocker, Inc.*(1)(2)(4)(5)
(3 shares)
|
Common Stock
|
12/19/2024
|
1,250,000
|
1,250,000
|
||
Information Technology—12.4%
|
||||||
BCPE Pequod Investor, L.P.*(1)(2)(4)(5)
|
Limited Partnership Interest
|
11/20/2024
|
923,416
|
923,077
|
||
Chronos Capital Fund, L.P.*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
04/29/2024
|
1,132,747
|
1,529,778
|
||
Novacap TMT VI Co-Investment (Invita), L.P.*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
11/08/2024
|
1,043,269
|
1,030,323
|
||
Utilities—7.9%
|
||||||
Greenbelt Capital Partners Saber L.P.*(1)(2)(4)(5)
|
Limited Partnership Interest
|
10/25/2023
|
1,249,375
|
2,229,712
|
||
|
|
|
|
|
11,740,410
|
13,404,007
|
Secondary Direct Equity—35.0%
|
||||||
Consumer Discretionary—4.9%
|
||||||
Equip Capital SPV SCSp*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
08/23/2024
|
1,272,261
|
1,364,858
|
||
Health Care—3.4%
|
||||||
Ourvita Build-Up SCSp*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
11/16/2023
|
720,102
|
971,389
|
||
Information Technology—2.6%
|
||||||
Diamant 244. GmbH*(1)(2)(4)(5)
(205 shares)
|
Common Stock
|
12/16/2024
|
541,692
|
540,527
|
||
Diamant 247. GmbH (Shareholder Loan)*(1)(2)(4)(5)
|
Loan Notes
|
12/19/2024
|
179,001
|
179,314
|
||
Health Care—9.6%
|
||||||
Investcorp India Investments Holding Parent Limited*(1)(2)(4)(5)(7)
(12 shares)
|
Preferred Stock
|
10/31/2024
|
24,400
|
157,513
|
||
Investcorp India Investments Holding Parent Limited (Shareholder Loan)*(1)(2)(4)(5)(7)
(12 shares)
|
Loan Notes
|
10/31/2024
|
1,195,600
|
1,195,600
|
||
KL Champion Blocker PI LLC*(1)(2)(4)(5)
|
Limited Partnership Interest
|
05/01/2024
|
1,251,284
|
1,343,997
|
||
Industrials—12.2%
|
||||||
HCI Equity Partners EV I, L.P.*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
09/09/2024
|
1,003,173
|
1,080,527
|
||
TRP Continuation Fund (Genox), LP*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
02/22/2024
|
1,095,745
|
1,295,031
|
||
VSC EV3 (Parallel) LP*(1)(2)(3)(4)(5)
|
Limited Partnership Interest
|
12/19/2023
|
739,259
|
1,044,671
|
|
1
|
|
Investments†—101.6%
|
Investment
Type
|
|
|
Acquisition
Date
|
Cost
|
Fair
Value
|
Information Technology—2.3%
|
||||||
Investcorp India Private Equity Holdings Limited*(1)(2)(4)(5)(6)(7)
(6 shares)
|
Preferred Stock
|
09/16/2024
|
$12,800
|
$12,800
|
||
Investcorp India Private Equity Holdings Limited (Shareholder Loan)*(1)(2)(4)(5)(6)(7)
(6 shares)
|
Loan Notes
|
09/16/2024
|
627,200
|
627,200
|
||
|
|
|
|
|
8,662,517
|
9,813,427
|
|
|
|
Interest
Rate
|
Shares
|
Cost
|
Fair Value
|
Short-Term Investments—18.9%
|
||||||
Prime Liquidity Fund LLC(2)
|
4.63%(8)
|
4,750,000
|
$4,750,000
|
$4,750,000
|
||
Federated Hermes Prime Private Liquidity Fund(2)
|
4.49%(8)
|
550,000
|
550,000
|
550,000
|
||
Total Short-Term Investments
|
|
|
|
|
5,300,000
|
5,300,000
|
Total Investments (Cost $25,702,927)
|
$28,517,434
|
|||||
Other Assets and Liabilities – (1.6%)
|
(452,047
)
|
|||||
Net Assets – 100.0%
|
$28,065,387
|
*
|
Non-income producing.
|
(1)
|
Investment valued using significant unobservable inputs.
|
(2)
|
All or a portion of this security is held through Hartford Funds SPV, LLC, a wholly-owned
subsidiary of the Fund.
|
(3)
|
Investment has been committed to but has not been fully funded by the Fund.
|
(4)
|
Investment does not allow redemptions or withdrawals except at discretion of its general
partner, manager or advisor.
|
(5)
|
Restricted security.
|
(6)
|
Currently no rate available.
|
(7)
|
Perpetual maturity security.
|
(8)
|
Current yield as of period end.
|
|
2
|
|
Description
|
Total
|
Level 1
|
Level 2
|
Level 3
|
Assets
|
|
|
|
|
Direct Investments
|
$23,217,434
|
$—
|
$—
|
$23,217,434
|
Short-Term Investments
|
5,300,000
|
5,300,000
|
—
|
—
|
Total
|
$28,517,434
|
$5,300,000
|
$—
|
$23,217,434
|
|
Direct Investments
|
Total
|
|
|
|
|
Beginning balance
|
$5,512,883
|
$5,512,883
|
|
|
|
|
Purchases
|
14,004,907
|
14,004,907
|
|
|
|
|
Sales
|
(3,678
)
|
(3,678
)
|
|
|
|
|
Total realized gain/(loss)
|
(141
)
|
(141
)
|
|
|
|
|
Net change in unrealized appreciation/(depreciation)
|
2,037,635
|
2,037,635
|
|
|
|
|
Transfers into Level 3
|
1,665,828
|
1,665,828
|
|
|
|
|
Transfers out of Level 3
|
—
|
—
|
|
|
|
|
Ending balance
|
$23,217,434
|
$23,217,434
|
|
|
|
|
For the period ended December 31, 2024, investments valued at $1,665,828 and excluded
from the fair value hierarchy were transferred into Level 3 due to the use of significant
unobservable inputs. There were no transfers out of Level 3.
|
||||||
The change in net unrealized appreciation/(depreciation) relating to the Level 3 investments
held at December 31, 2024 was $2,037,635.
|
|
3
|
|